Saturday, January 8, 2011

Preventing the ubiquitin/proteasome-dependent degradation of frataxin, the protein defective in Friedreich’s Ataxia

Human Molecular Genetics doi:10.1093/hmg/ddq566

Alessandra Rufini, Silvia Fortuni, Gaetano Arcuri, Ivano Condo’, Dario Serio, Ottaviano Incani, Florence Malisan, Natascia Ventura, Roberto Testi

kEYWORDS: Friedreich’s Ataxia (FRDA),frataxin, mitochondrial defects, oxidative damage, frataxin stability and degradation, ubiquitin-proteasome system, K147, K147R substitution, aconitase activity, ATP levels, therapeutic potential, frataxin degradation pathway.

A registry of registries? The US backs the idea for patients

Nature Medicine Volume:17, Page:4 Year published: (2011)
DOI:10.1038/nm0111-4a, Published online 07 January 2011

Monica Heger

"The database would serve patients and physicians looking for specific disease registries, researchers investigating a particular disease and drug developers".

Keywords: ClinicalTrials.gov, registry, federally and privately funded clinical trials, world, registry of patient registries.